Vaccine Logistics Market Size
| Study Period | 2020 - 2029 |
| Market Size (2024) | USD 3.13 Billion |
| Market Size (2029) | USD 4.04 Billion |
| CAGR (2024 - 2029) | 5.20 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | Europe |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Vaccine Logistics Market Analysis
The Vaccine Logistics Market size is estimated at USD 3.13 billion in 2024, and is expected to reach USD 4.04 billion by 2029, growing at a CAGR of 5.20% during the forecast period (2024-2029).
The wide variety of new vaccines and immunization schedules and service delivery strategies, the expanding target population, the increased cold-chain infrastructure requirements, and insufficient funding are some of the new realities that may further impact the vaccine transportation market.
The existing systems are struggling to keep pace with the changing landscape of national and international immunization programs, especially after the development of the COVID-19 vaccine, resulting in stock-outs, avoidable wastage, and inadequate cold-chain capacity. All the aforementioned factors have considerable coverage, performance, and cost implications.
Due to the enormous rise in demand for vaccine storage services brought on by the COVID-19 epidemic, pharmaceutical companies focused their efforts on creating cold chain logistics. Therefore, the vaccine cold chain logistics market will probably see new growth prospects in the coming years due to the increasing R&D initiatives.
Vaccine Logistics Market Trends
Growth in the Pharmaceutical Sector
With government initiatives to improve the pharmaceutical industry's growth worldwide and fuel competition within the market, the demand for pharma logistics may increase globally. As strong growth continues across the global pharmaceuticals industry, the sub-category of temperature-controlled products is also surging. Pharmaceutical manufacturers around the world are increasingly focusing on product quality and sensitivity. The development of complex biological-based medicines and the shipment of hormone treatments, vaccines, and complex proteins, which require cold chain refinements, result in a need for temperature-controlled transportation and warehousing.
Temperature-controlled logistics for pharmaceutical products and medical devices is a significantly growing segment of the healthcare logistics industry. Moreover, the increase in the need for effective cold chain logistics services to maintain the quality of goods is fueling the growth of the market.
Demand for innovative drugs will drive oncology spending to approximately USD 370 billion by 2027, almost double the current level.
India is the largest provider of generic medicines globally, occupying a 20% share in global supply by volume, and is the leading vaccine manufacturer globally with a market share of 60%.
The rising importance of fast-track assistance in the healthcare sector is also driving the market for pharmaceutical logistics. Moreover, decreasing the distribution cost by creating a single-source distribution channel is boosting the demand for pharmaceutical logistics.
Development in Cold Chain Logistics
Thermal stability is not a property of most vaccines, including those used against diphtheria, tetanus, pertussis (DTP), and measles, mumps, and rubella (MMR). Typically, vaccines that are not heat-stable and not properly refrigerated spoil over a short period because these vaccines contain biological matter that degrades when not stored between 2°C and 8°C. As a result, most vaccines rely on refrigerated or cold-chain distribution, which consists of several stages.
The refrigerated trucks that can hold goods in multiple segments at different temperatures are being developed further and gaining popularity. Cold chain service providers are also installing radio-frequency identification (RFID) and Industrial Internet of Things (IIoT) to help address cold chain inefficiencies by providing increased insights into the location, properties, and condition of sensitive products.
Companies are also developing high-tech containers with a closed temperature-controlled system to deliver temperature-sensitive goods between cargo warehouses and aircraft seamlessly. These containers are specially designed to serve the pharmaceutical industry.
In Aug 2022, Azenta Inc. has agreed to acquire B Medical Systems S.á r.l. and its subsidiaries. This acquisition expands Azenta's cold chain capabilities by providing distinct solutions for safely and traceably transporting temperature-sensitive specimens. As part of Azenta, B Medical will gain substantial knowledge and engineering skills in sample management and an expanded market presence in North America and Europe.
Vaccine Logistics Industry Overview
The vaccine logistics market is fragmented and is dominated by international companies, such as Yamato, Deutsche Post DHL Group, and Nippon Express. These international companies are focusing on expansion strategies through acquisitions. Their strong presence helps them expand in the market more easily than the smaller players.
With the COVID-19 pandemic, the market is expected to experience an increased demand for refrigerated warehouses, fast and controlled delivery services, and the bulk transportation of vaccines, backed by the increasing government investment providing opportunities to the players in the market to expand their reach and efficiency in the long run.
Vaccine Logistics Market Leaders
-
DHL Global Forwarding
-
AllCargo Logistics
-
American Airlines
-
DB Schenker
-
FedEx Corporation
*Disclaimer: Major Players sorted in no particular order
Vaccine Logistics Market News
- June 2023: DHL Supply Chain entered into an agreement with Vizient, one of the largest member-driven healthcare performance improvement companies in the United States, to become a qualified supplier of supply chain third-party logistics (3PL) services. The agreement allows Vizient members, including hospital systems and healthcare suppliers, increased access to best-in-class service logistics solutions delivered by DHL Supply Chain.
- January 2023: AmerisourceBergen Corporation completed the acquisition of PharmaLex Holding GmbH. The acquisition of PharmaLex enhances AmerisourceBergen’s growth strategy by advancing its leadership in specialty services and global platform of pharma manufacturer services capabilities. PharmaLex’s regulatory affairs, development consulting and scientific affairs, pharmacovigilance, and quality management and compliance services expand AmerisourceBergen’s role as partner of choice for biopharmaceutical partners across the pharmaceutical development and commercialization journey.
- Nov 2022,UPS has completed its previously announced acquisition of Bomi Group, a leading multi-national healthcare logistics business. UPS Healthcare, the company's healthcare division, will add temperature-controlled facilities in 14 countries, as well as 3,000 highly experienced professionals to the UPS team across Europe and Latin America, as a result of the acquisition.
Vaccine LogisticsMarket Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
- 2.1 Analysis Methodology
- 2.2 Research Phases
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS AND INSIGHTS
- 4.1 Current Market Scenario
-
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.1.1 technology innovation in temperature controlled packaging
- 4.2.1.2 Cross Border collaborations and initiative to enhance healthcare infrastructure
- 4.2.2 Restraints
- 4.2.2.1 Supply chain distruption and transportation bottlenecks can hinder timely vaccine distribution
- 4.2.3 Opportunities
- 4.2.3.1 Adoption of blockchain and IoT technology can improve transparency and tracebility
- 4.3 Technological Trends and Automation
- 4.4 Government Regulations and Initiatives
- 4.5 Industry Value Chain/Supply Chain Analysis
- 4.6 Spotlight on Ambient/Temperature-controlled Storage
- 4.7 Industry Attractiveness - Porter's Five Forces Analysis
- 4.8 Impact of COVID-19 on the Market
5. MARKET SEGMENTATION
-
5.1 By Service
- 5.1.1 Transportation
- 5.1.1.1 Land (Road and Rail)
- 5.1.1.2 Air
- 5.1.1.3 Sea
- 5.1.2 Warehousing
- 5.1.3 Value-added Services (Packaging, Labeling, etc.)
-
5.2 By End User
- 5.2.1 Hospitals
- 5.2.2 Drug Manufacturers and Distributors
- 5.2.3 Other End Users (Blood Banks, Clinics, etc.)
-
5.3 By Geography
- 5.3.1 Asia-Pacific
- 5.3.1.1 China
- 5.3.1.2 Japan
- 5.3.1.3 Australia
- 5.3.1.4 India
- 5.3.1.5 Singapore
- 5.3.1.6 Malaysia
- 5.3.1.7 Indonesia
- 5.3.1.8 Thailand
- 5.3.1.9 South Korea
- 5.3.1.10 Rest of Asia-Pacific
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 France
- 5.3.2.3 United Kingdom
- 5.3.2.4 Italy
- 5.3.2.5 Rest of Europe
- 5.3.3 North America
- 5.3.3.1 United States
- 5.3.3.2 Canada
- 5.3.3.3 Mexico
- 5.3.4 South America
- 5.3.4.1 Brazil
- 5.3.4.2 Colombia
- 5.3.4.3 Argentina
- 5.3.4.4 Rest of South America
- 5.3.5 Middle East
- 5.3.5.1 Egypt
- 5.3.5.2 Qatar
- 5.3.5.3 Saudi Arabia
- 5.3.5.4 United Arab Emirates
- 5.3.5.5 Rest of the Middle East
6. COMPETITIVE LANDSCAPE
- 6.1 Market Concentration Overview
-
6.2 Company Profiles*
- 6.2.1 DHL Global Forwarding
- 6.2.2 AllCargo Logistics
- 6.2.3 American Airlines
- 6.2.4 DB Schenker
- 6.2.5 FedEx Corporation
- 6.2.6 Kuehne Nagel
- 6.2.7 Nippon Express
- 6.2.8 Yamato Logistics
- 6.2.9 Americold Logistics
- 6.2.10 lynden international logistics
- 6.2.11 DP World
- 6.2.12 Coldman Logistics
- 6.2.13 Cavalier Logistics*
- 6.3 Other Companies
7. FUTURE OF THE GLOBAL VACCINE LOGISTICS MARKET
8. APPENDIX
** Subject To AvailablityVaccine Logistics Industry Segmentation
Vaccines are widely used as one of the prevention strategies to control infectious diseases. The study on global vaccine transportation covers an analysis of the logistics and storage facilities dedicated to the transportation of vaccines around the world.
The report also covers an assessment of the global economy, emerging trends by segments and regional markets, significant changes in market dynamics, and a market overview. The report also covers the impact of COVID-19 on the market.
The vaccine logistics market is segmented by service (transportation, warehousing, and value-added services (packaging, labeling, etc.), end user (hospitals, drug manufacturers and distributors, and other end users (blood banks, clinics, etc.)), and geography (Asia-Pacific, Europe, North America, South America, and the Middle East). The report offers market size and forecasts in value (USD) for all the above segments.
| By Service | Transportation | Land (Road and Rail) |
| Air | ||
| Sea | ||
| By Service | Warehousing | |
| Value-added Services (Packaging, Labeling, etc.) | ||
| By End User | Hospitals | |
| Drug Manufacturers and Distributors | ||
| Other End Users (Blood Banks, Clinics, etc.) | ||
| By Geography | Asia-Pacific | China |
| Japan | ||
| Australia | ||
| India | ||
| Singapore | ||
| Malaysia | ||
| Indonesia | ||
| Thailand | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| By Geography | Europe | Germany |
| France | ||
| United Kingdom | ||
| Italy | ||
| Rest of Europe | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| By Geography | South America | Brazil |
| Colombia | ||
| Argentina | ||
| Rest of South America | ||
| By Geography | Middle East | Egypt |
| Qatar | ||
| Saudi Arabia | ||
| United Arab Emirates | ||
| Rest of the Middle East |
Vaccine LogisticsMarket Research FAQs
How big is the Vaccine Logistics Market?
The Vaccine Logistics Market size is expected to reach USD 3.13 billion in 2024 and grow at a CAGR of 5.20% to reach USD 4.04 billion by 2029.
What is the current Vaccine Logistics Market size?
In 2024, the Vaccine Logistics Market size is expected to reach USD 3.13 billion.
Who are the key players in Vaccine Logistics Market?
DHL Global Forwarding, AllCargo Logistics, American Airlines, DB Schenker and FedEx Corporation are the major companies operating in the Vaccine Logistics Market.
Which is the fastest growing region in Vaccine Logistics Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Vaccine Logistics Market?
In 2024, the Europe accounts for the largest market share in Vaccine Logistics Market.
What years does this Vaccine Logistics Market cover, and what was the market size in 2023?
In 2023, the Vaccine Logistics Market size was estimated at USD 2.98 billion. The report covers the Vaccine Logistics Market historical market size for years: 2020, 2021, 2022 and 2023. The report also forecasts the Vaccine Logistics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Vaccine LogisticsIndustry Report
Statistics for the 2024 Vaccine Logistics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Vaccine Logistics analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
